首页> 外文OA文献 >Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery

【2h】

Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery

机译：同工肿瘤模型的纵向免疫表征，使免疫肿瘤药物发现的模型选择

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Molly A. Taylor; Adina M. Hughes; Josephine Walton; Anna M. L. Coenen-Stass; Lukasz Magiera; Lorraine Mooney; Sigourney Bell; Anna D. Staniszewska; Linda C. Sandin; Simon T. Barry; Amanda Watkins; Larissa S. Carnevalli; Elizabeth L. Hardaker;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery [J] . Molly A. Taylor, Adina M. Hughes, Josephine Walton, Journal for ImmunoTherapy of Cancer . 2019,第1期

机译：同源肿瘤模型的纵向免疫特征可实现免疫肿瘤学药物发现的模型选择
2. Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery [J] . Molly A. Taylor, Adina M. Hughes, Josephine Walton, Journal for ImmunoTherapy of Cancer . 2019,第1期

机译：同源肿瘤模型的纵向免疫特征可实现免疫肿瘤学药物发现的模型选择
3. Immunophenotyping, RNAseq, microbiota analysis of syngeneic mouse models treated with immune checkpoint inhibitors to support biomarker and immune-oncology drug discovery [J] . Zhang L., Qiao M., Zhang J., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Null期

机译：免疫分型，RNAseq，经免疫检查点抑制剂处理以支持生物标记和免疫肿瘤学药物发现的同系小鼠模型的微生物群分析
4. A mCD3xP-Cadherin Mouse Bispeciflc Allows Immune Profiling of T Cell and Myeloid Cell Populations During Treatment of Syngeneic Mouse Tumor Models [C] . Holly A. Jensen Yongjing Jane Guo, Mary Mileski, Chad Stevens, Protein Engineering Summit. . 2018

机译：MCD3XP-CADHERIN小鼠BISPECIFLC允许在治疗同胞小鼠肿瘤模型期间免疫分析T细胞和骨髓细胞群
5. B7H6-targeting Bispecific T Cell Engager Induced Immune Responses in Syngeneic Murine Lymphoma and Melanoma Tumor Models [D] . Coupet, Tiffany Alexandra. 2020

机译：B7H6 - 靶向双特异性T细胞参与诱导在Synegentic鼠淋巴瘤和黑色素瘤肿瘤模型中的免疫应答
6. Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery [O] . Molly A. Taylor, Adina M. Hughes, Josephine Walton, 2019

机译：同源肿瘤模型的纵向免疫表征可用于免疫肿瘤学药物发现的模型选择
7. Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery [O] . Mosely S.I.S., Prime J.E., Sainson R.C.A., 2017

机译：合理选择用于免疫治疗药物发现的同源临床前肿瘤模型
8. Formulated Delivery of Enzyme/Pro-Drug and Cytokine Gene Therapy to Promote Immune Reduction of Treated and Remote Tumors in Mouse Models of Prostate Cancer [R] . Russell, P. 2005

机译：配方提供酶/前药和细胞因子基因治疗促进小鼠前列腺癌模型中治疗和远程肿瘤的免疫减少

Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery

著录项

相似文献

相关主题

期刊订阅